Agile Therapeutics to Participate in Upcoming March Investor Events
11 3월 2022 - 10:01PM
Agile Therapeutics, Inc. (Nasdaq: AGRX), a women’s healthcare
company, today announced that Chairman and Chief Executive Officer
Al Altomari will participate in two upcoming investor conferences,
including a live panel discussion on drug development in Women’s
Health.
- Oppenheimer’s 32nd
Annual Virtual Healthcare Conference
- Fireside Chat
- Thursday, March 17, 2022 at 2:00 p.m. ET
- Maxim Group and M-Vest 2022 Virtual Growth
Conference
- Advances in Women’s Health, from Clinical to Commercial Live
Panel Discussion
- Monday, March 28, 2022 at 3:00 p.m. ET
Links and webcast information for each conference can be found
on the Investors section of the Agile Therapeutics website
at https://ir.agiletherapeutics.com/events-and-presentations.
Each archived webcast will be available for 30 days.
About Agile Therapeutics, Inc.Agile
Therapeutics is a women’s healthcare company dedicated to
fulfilling the unmet health needs of today’s women. Our
product and product candidates are designed to provide women with
contraceptive options that offer freedom from taking a daily pill,
without committing to a longer-acting method. Our initial
product, Twirla®, (levonorgestrel and ethinyl estradiol), a
transdermal system, is a non-daily prescription contraceptive.
Twirla is based on our proprietary transdermal patch technology,
called Skinfusion®, which is designed to allow drug delivery
through the skin. For more information, please visit the company
website at www.agiletherapeutics.com. The Company may
occasionally disseminate material, nonpublic information on the
Company’s website.
Contact:
Matt Riley
Head of Investor Relations & Corporate Communications
mriley@agiletherapeutics.com
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Agile Therapeutics (NASDAQ:AGRX)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024